Category Archives: Scientifique

The CCM was selected to perform live cases at the 9th Multi Level CTO Course held in Nice from 27 to 29 June.

During the 3 days of this international congress, dedicated exclusively to the treatment of chronic total coronary occlusions, 4 live cases were performed at the CCM, enabling interventional cardiologists to follow real cases of increasing complexity live. They were performed by the Centre’s team of interventional cardiologists, accompanied by guest practitioners.

The treatment of CTO by recanalization of chronic total coronary occlusions has become a must-have procedure, a specificity of interventional cardiology that is booming and constantly evolving. Mastering CTO techniques is now essential for managing complex coronary patients.

    Watch Monaco Info report

Pr. Sylvie DI FILIPPO
Monaco Cardiothoracic Center.
Pediatric and adult congenital cardiology & fetal cardiology.
University professor, hospital practitioner.

Congenital heart disease is the most common congenital organ anomaly. Their incidence in the general population is 14 foetuses per 1000 and 8 births per 1000.
Congenital heart disease includes multiple malformations of varying anatomical and functional complexity and with heterogeneous prognoses.

These malformations are classified according to their severity and complexity into:

• Minor, moderate and major
• Repairable and non-repairable
• Biventricular and univentricular
• Cyanogenic and non-cyanogenic

Minor heart disease No need for intervention	Moderate heart disease Intervention indicated Repairable heart disease	Severe heart disease Heart disease requiring treatment and intervention Repairable with sequelae or non-repairable
Bicuspid aortic valve Small atrial septal defect Small interventricular septal defect Small ductus arteriosus Minor mitral valve anomaly Minor pulmonary narrowing	Pulmonary vein anomalies Coronary anomalies Aortic stenosis Atrioventricular canal Large AIC Large IVC Large ductus arteriosus Aortic coarctation Tight pulmonary stenosis Marfan’s disease and aortic aneurysm Ebstein’s tricuspid anomaly Tetralogy of Fallot Transposition of large vessels after repair	Heart disease with fixed pulmonary hypertension (Eisenmenger) Non-operated or palliated cyanotic heart disease Interruption of the aortic arch Right ventricle with double outlet Single ventricles Pulmonary atresia Common arterial trunk Univentricular Fontan circulation Transposition of the great vessels with right ventricle under the aorta Complex heart disease with multiple lesions

Anatomo-physiopathological classification of congenital heart disease

• Left-right shunts
• Right-to-left shunts and right obstructions
• Left obstructions
• Coronary anomalies
• Rhythmological abnormalities
• Complex heart disease

Shunt: natural or created abnormal communication between heart chambers or vessels.
Cyanosis: blue discolouration of the skin and mucous membranes due to a drop in oxygen in the blood (or hypoxia).

Antenatal screening

• Congenital heart disease is well tolerated during intrauterine life and does not prevent normal development of the foetus.
• Adaptation to extra-uterine life, which involves a fall in pulmonary pressures and closure of the ductus arteriosus and foramen ovale, is the cause of decompensation of cardiac malformations, the viability of which depends on the permeability of these shunts.
• Antenatal diagnosis of heart disease by echocardiography and Doppler enables decompensation to be anticipated and prevented, by guiding immediate post-natal therapeutic management. The birth is programmed and planned by the gynaeco-obstetric and neonatology team.
• In the majority of cases, pre-term induction is not necessary. Only cases of fetal heart failure may justify it (the consequence of an abnormal heart rhythm, either too slow = fetal bradycardia, or too fast = uncontrolled fetal tachycardia).
• Antenatal screening enables heart disease to be diagnosed, with results ranging from 40% to 90% depending on the type of heart disease.
• It enables a diagnosis to be made, the course of the disease to be monitored antenatally, postnatal care to be planned and the prognosis to be established.
• Birth planned in this way helps prevent decompensation of the heart disease after birth
• The prostaglandin E1 administered is a treatment that keeps the ductus arteriosus open at birth, thereby maintaining circulation and/or oxygenation in newborns with heart disease at risk of acute decompensation.
• Heart diseases at risk of neonatal decompensation entail a lethal risk, including::
  – Right-sided obstructions that limit pulmonary flow
  – Left-sided obstructions that limit aortic flow
  – Mixing anomalies that depend on the patency of the foramen ovale

Diagnosis and clinical symptoms

Newborn

• Cyanosis, heart failure
• Shunt-dependent heart disease

Symptoms

• Feeding difficulties
• Poor growth or weight stagnation
• Frequent bronchopulmonary infections
• Dyspnoea on exertion
• Feeling unwell, syncope
• Chest pain

Asymptomatic

• Breathing
• ECG abnormality discovered by chance
• Abnormalities on clinical examination: femoral pulses, high blood pressure

Cardiac and Doppler ultrasound: cardiac ultrasound is a simple, non-invasive examination that can be used to diagnose cardiac malformations at any age.

Neonatology

Screening for congenital heart disease

Antenatal

heart disease detected antenatally must be confirmed postnatally by a cardiac ultrasound scan of the newborn.

Postnatally

not all heart disease is detected before birth, and it is still very important to examine all newborn babies in the maternity unit to look for any heart abnormality that may have gone unrecognised, and to recognise it before the baby is discharged home.

The clinical examination should look for :

• palpation of the femoral pulses
• The presence of a murmur on ausculation
• The newborn’s feeding behaviour
• Oxygen saturation or satO2: systematic screening for heart disease in newborns is carried out in maternity units by measuring oxygen saturation in the upper and lower limbs. The normal level is > 97%, with a difference of less than 3% between the upper and lower limbs. If this measurement is abnormal, an echocardiogram is performed to check for any cardiac abnormality before the baby is discharged from the maternity hospital.

Imaging congenital heart disease

IRM

Magnetic resonance imaging makes a major contribution to the assessment of congenital heart disease, particularly in adulthood, when the performance of echocardiography is less good.
MRI provides additional information that is essential for assessment, follow-up, diagnosis, management and therapeutic decisions.
It allows :

• Anatomical assessment of cavities and vessels
• Functional assessment: of myocardial function
• Analysis of flow and output
• Search for myocardial fibrosis
• Testing for ischaemia using the adenosine test

Its use is limited in children because of the need for sedation
The main indications are systemic right ventricles (double mismatch, transposition of the great vessels with atrial switch), right ventricles with volume overload (tetralogy of Fallot), single ventricles, pulmonary, aortic, tricuspid and mitral valve disease, aortic pathologies, etc.

SCANNER

The angio-scanner is a complementary imaging technique which allows the vessels to be viewed in particular:

• pulmonary arteries
• pulmonary veins
• coronary arteries
• aorta
• veno-venous and arteriovenous fistulas

Its use is limited by irradiation and injection of potentially nephrotoxic and allergenic contrast medium.

Congenital heart disease in adulthood

• Over 90% of children with congenital heart disease (CHD) survive into adulthood.
• The number of adults with CHD is now greater than the number of children.
• Most of these patients cannot be considered cured, and their management is a lifelong process: from repair in childhood, to the transition to adulthood, to the desire for pregnancy, and the management of late complications specific to each CC.

Transition to adulthood

The transition to adulthood is an important phase that needs to be anticipated and supported, so that patients can receive all the information they need about their heart disease, their medical history, their treatment, their follow-up and all the problems associated with their heart disease.
To this end, therapeutic education programmes have been developed and set up in the referral centres.

At the CCM: the transition is made naturally by an organisation based on a medical-surgical team caring for the same patients from foetus to adulthood.

Complications of congenital heart disease in adulthood:

• Surgical revision: valvulopathy, dilated aorta, residual shunt
• Myocardial dysfunction: left ventricle, single ventricle, systemic right ventricle
• Coronary artery disease
• Heart failure
• Arrhythmias
• Infectious endocarditis
• Arterial hypertension

Transmission and genetics of congenital heart disease

Embryology of the normal heart: the heart is formed during the first 8 weeks of foetal life, in several successive complex stages starting from the primitive cardiac tube, with phenomena of torsion and rotation and partitioning:

• Primitive heart tube
• Loop: position of the atria/ventricles cavities
• Formation of the atrioventricular valves
• Partitioning of the atria
• Partitioning of the ventricles
• Partitioning of the vessels

Congenital heart disease is inherited through a multifactorial mechanism involving both genetic and environmental factors.
In the majority of cases (72%), no genetic aetiology is identifiable.

• Genetic and environmental factors: account for 20% to 30% of cases
• Environmental factors: 2% of cases

Maternal illnesses: diabetes, rubella, systemic lupus erythematosus.
Maternal use of treatments such as lithium, isotretinoin and anticonvulsants.
Maternal age: this is a risk factor for trisomy 21, which can lead to heart malformations.

• Chromosomal abnormalities (aneuploidies): 10%.

trisomy 21 or Down syndrome, trisomy 18, trisomy 13, monosomy X or Turner syndrome

• Subchromosomal deletions (microdeletions), subchromosomal duplications, single-gene mutations

monogenic: congenital syndromes affecting multiple organs
Di George syndrome (microdeletion 22q11.2)
Williams-Beuren syndrome (microdeletion 7p11.23)
Single gene defects: fibrillin-1 mutations (Marfan syndrome), TXB5 (Holt-Oram syndrome)
PTPN11 (Noonan syndrome).

• Autosomal dominant de novo point mutation: 8%.
• Autosomal recessive inherited point mutation: 2%.

The risk of recurrence of congenital heart disease in a family depends on the cause: negligible in de novo mutations, 2 to 5% in non-syndromic multifactorial congenital heart disease, and 50% when an autosomal dominant mutation is involved.
It is important to identify genetic factors in order to assess the risk of recurrence and to guide preconception genetic counselling.